Please Wait
Applying Filters...
menu
    • menu
    J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

    Data Compilation
    #PharmaFlow

    Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

    Stock Recap
    #PipelineProspector

    Menu

    MolPort-001-738-625

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 36Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    28/06/2025 Yoshindo
    Japan
    		 Yoshindo Co., Ltd. 218MF10448 JP Norfloxacin (for manufacturing only) 2006-04-27 2007-12-19 3697-8 Hagishima, Funauchi-cho, Toyama City, Toyama Prefecture
    28/06/2025 Yoshindo
    Japan
    		 Yoshindo Co., Ltd. 225MF10086 Norfloxacin (N) 2013-04-23 2013-04-23 3697-8 Hagishima, Funauchi-cho, Toyama City, Toyama Prefecture